KENYA – Kenyan researchers have reportedly found two new strains of two common sexually transmitted diseases, gonorrhea and chlamydia, among a group of women in a town in western Kenya.

Researchers at the Kenya Medical Research Institute (KEMRI) have diagnosed the two diseases with new mutations in more than 400 women over the age of 15 and fear the disease could spread to neighboring Uganda as the Busia town located along the border, is very popular with truck drivers.

The researchers are planning to conduct further studies to establish how widespread the disease is and whether the new mutations can be treated with standard antibiotics. The researchers added that changes to the genetic makeup of the virus had never been seen before.

Shillah Simiyu, a Kenyan epidemiologist, said that Busia presents high sexually transmitted disease numbers due to increased sexual activities by virtue of being a border town where truck drivers stop. Simiyu says there is an urgent need to conduct a mixed methods study involving social, epidemiological and laboratory science approaches.

The researchers are planning to conduct more studies to establish how widespread the disease is and whether the new mutations can be treated by standard antibiotics. They said the changes on the genetic makeup of the virus had not been seen before.

In January 2023, medics said the drug-resistant super gonorrhoea was first detected in samples taken from sex workers in the capital city, Nairobi, and other urban areas like Kiambu County. 

The medical investigation was prompted by reports by medics indicating there was a surge in cases of patients seeking treatment for STIs towards the end of 2022, Dr. Amina Abdullahi, one of the researchers who made the discovery at Kemri, told the local press, according to a report from DownToEarth.

The outbreak of Neisseria gonorrhoea is not just a threat to the citizens of the East African anchor state but the region as a whole, according to experts. Gonorrhoea is the second-most common disease to be sexually transmitted across the world after chlamydia, according to the World Health Organization (WHO).

Documents by Kenya’s ministry of health, including The Kenya National Guidelines for Prevention, Management, and Control of STIs show that Kenya’s infertility prevalence is estimated to be 11.9%.

The country’s infertility is likely to increase with the outbreak of drug-resistant gonorrhoea and other eventual STIs, researchers at Kemri and other medical experts have warned. This can have devastating effects on the country’s development agenda.

A majority of Kenyans reportedly buy antibiotics and never seek treatment, promoting the mutation of STIs. A quick survey of chemists around Nairobi showed that medication to treat ‘STI-like symptoms’ is among their top ten frequently purchased products.

For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.